Effects of N-acetylcysteine, deferoxamine and selenium on doxorubicin-induced hepatotoxicity

Biological Trace Element Research

Volumn 132, Issue 1-3, 2009, Pages 184-196

  Bulucu, Fatih ^a   Ocal, Ramazan ^a   Karadurmus, Nuri ^a   Sahin, Mustafa ^a   Kenar, Levent ^a   Aydin, Ahmet ^a   Oktenli, Cagatay ^a   Koc, Bayram ^a   Inal, Volkan ^b   Yamanel, Levent ^a   Yaman, Halil ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Military Hospital   (Turkey)

Author keywords

Deferoxamine; Doxorubicin hepatotoxicity; N acetylcysteine; Rat; Selenium

Indexed keywords

ACETYLCYSTEINE; ADRIBLASTINA FLACON; ANTIOXIDANT; ASIST AMPOULE; CATALASE; COPPER; DEFEROXAMINE; DESFERAL FLACON; DOXORUBICIN; GLUTATHIONE PEROXIDASE; IRON; MALONALDEHYDE; SELENIUM; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CELL PROTECTION; CLINICAL EVALUATION; CONTROLLED STUDY; COPPER BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; IRON BLOOD LEVEL; LIPID PEROXIDATION; LIVER; LIVER CELL DAMAGE; LIVER TOXICITY; MALE; NONHUMAN; RAT; SINGLE DRUG DOSE; URINALYSIS; ZINC BLOOD LEVEL;

ACETYLCYSTEINE; ANIMALS; CATALASE; COPPER; DEFEROXAMINE; DOXORUBICIN; GLUTATHIONE PEROXIDASE; IRON; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; RATS; RATS, SPRAGUE-DAWLEY; SELENIUM; SUPEROXIDE DISMUTASE; ZINC;

ANIMALIA; RATTUS;

EID: 72249123561     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12011-009-8377-y     Document Type: Article

References (42)

1. K Tomoki I Fujita N Itoh N Muto T Nakanishi K Takahashi J Azuma K Tanaka 2000 Metallothionein acts as a cytoprotectant against doxorubicin toxicity JPET 292 299 302
2. LJ Steinherz PG Steinherz CT Tan G Heller ML Murphy 1991 Cardiac toxicity 4 to 20 years after completing anthracycline therapy JAMA 266 1672 7 10.1001/jama.266.12.1672 1:STN:280:DyaK3MzlvFequg%3D%3D 1886191
3. PK Singal N Iliskovic 1998 Doxorubicin induced cardiomyopaty N Engl J Med 339 900 905 10.1056/NEJM199809243391307 1:STN:280:DyaK1cvhsVektw%3D%3D 9744975 (Pubitemid 28446849)
4. Y Kalender M Yel S Kalender 2005 Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats The effects of vitamin E and catechin Toxicology 209 39 45 10.1016/j.tox.2004.12.003 1:CAS:528:DC%2BD2MXhslCisb0%3D 15725512 (Pubitemid 40269501)
5. PE Ganey FC Kauffmann RG Thurman 1988 Oxygen-dependent hepatotoxicity due to doxorubicin:role of reducing equivalent supply in perfused rat liver Mol Pharmacol 34 695 701 1:CAS:528:DyaL1MXltVylsg%3D%3D 3193959
6. D Bagchi M Bagchi E Hassoun J Kelly SJ Stohs 1995 Adriamycin-induced hepatic and myocardial lipid-peroxidation and DNA damage, and enhanced excretion of urinary lipid metabolites in rats Toxicology 95 1 9 10.1016/0300-483X(94) 02867-T 1:CAS:528:DyaK2MXisVCntLY%3D 7825176
7. I Durak HS Öztürk M Kavutcu M Birey M Yel T Guven E Olcay M Kacmaz O canbolat 1998 Protective role of antioxidant vitamins on adriamycin-induced free radical production and cardiotoxicity in guinea pigs Cancer Res Ther Cont 5 133 141
8. DJ Marchand KW Renton 1981 Depression of cytochrome P-450-dependent drug biotrnsfomation by adriamycin Toxicol Appl Phamacol 58 83 88 10.1016/0041-008X(81)90118-6 1:CAS:528:DyaL3MXitValsLg%3D (Pubitemid 11102610)
9. JR Babson NS Abell DJ Reed 1981 Protective role of glutathione redox cycle against adriamycin-mediated toxicity in isolated hepatocytes Biochem Pharmacol 30 2299 2304 10.1016/0006-2952(81)90102-7 1:CAS:528: DyaL38XksF2gug%3D%3D 7295342 (Pubitemid 11048320)
10. F Afaq P Abidi Q Rahman 2000 N-acetyl L-cysteine attenuates oxidant-mediated toxicity induced by chrysotile fibers Toxicol Letter 117 53 60 10.1016/S0378-4274(00)00236-8 1:CAS:528:DC%2BD3cXntF2qsbo%3D (Pubitemid 30734359)
11. EL De Beer 2001 Bottone AE Voest EE: Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review: Eur J Pharmacol 415 1 11 11245845
12. L Gianni JL Zweier A Levy CE Myers 1985 Characterization of the cycle of iron-mediated electron transfer from adriamycin to molecular oxygen J Biol Chem 260 6820 6826 1:CAS:528:DyaL2MXktlajtr0%3D 2987234
13. BK Sinha PM Polliti 1990 Antracyclines Cancer Chemother Biol Resp Modifier Ann 11 45 57 1:STN:280:DyaK3M%2Fis1yjtA%3D%3D
14. EE Voest G Vreugdenhil JJM Marx 1994 Iron-chelating agents in non-iron overload conditions Ann Inter Med 120 490 499 1:STN:280:DyaK2c7ksV2rsw%3D%3D
15. TC Stadtman 1980 Selenium-dependent enzymes Annu Rev Biochem 49 93 110 10.1146/annurev.bi.49.070180.000521 1:CAS:528:DyaL3cXks1Cht7k%3D 6996574
16. A Stajn RV Zikic B Ognjanovic ZS Saicic SZ Pavlovic MM Kostic VM Petrovic 1997 Effect of cadmium and selenium on the antioxidant defence system in rat kidneys Comp biochem Physiol 117C 167 172 1:CAS:528:DyaK2sXjvValtrs%3D
17. F Bulucu C Oktenli L Kenar B Koc R Ocal N Karadurmus V Inal L Yamanel YS Sanisoǧlu A Aydin 2007 Detrimental effects of N-acetylcysteine plus desferoxamine combination in an experimental nephrotic syndrome model Int J Toxicol. 26 525 532 10.1080/10915810701707403 1:CAS:528:DC%2BD2sXhsVSnsbjN 18066968 (Pubitemid 350232908)
18. F Bulucu C Oktenli L Kenar B Koc R Ocal V Inal L Yamanel H Yaman YS Sanisoǧlu A Aydin 2008 Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with adriamycin-induced nephrotic syndrome J Nephrol 21 576 583 1:CAS:528:DC%2BD1cXhsFWgsrrE 18651549
19. A Aydin H Orhan A Sayal M Ozata G Sahin A Isimer 2001 Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control Clin. Biochem. 134 65 70 10.1016/S0009-9120(00)00199-5 (Pubitemid 32178508)
20. H Aebi 1984 Catalase in vitro Methods. Enzymol. 105 121 6 10.1016/S0076-6879(84)05016-3 1:CAS:528:DyaL2cXltVKis7s%3D 6727660
21. KR Atkuri JJ Mantovani LA Herzenberg LA Herzenberg 2007 N-Acetylcysteine-a safe antidote for cysteine/glutathione deficiency Curr Opin Pharmacol. 7 355 359 10.1016/j.coph.2007.04.005 1:CAS:528:DC%2BD2sXpsFKqsrs%3D 17602868 (Pubitemid 47289259)
22. A Gokcimen A Cim HT Tola D Bayram A Kocak F Ozguner A Ayata 2007 Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity Hum Exp Toxicol 26 519 525 10.1177/0960327107076885 1:CAS:528:DC%2BD2sXhtVWiu7fE 17698947 (Pubitemid 47224747)
23. B Haliwell 1989 Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action? Free Radic biol Med 7 645 651 10.1016/0891-5849(89)90145-7 (Pubitemid 20027483)
24. K Schwarz CM Foltz 1957 Selenium as an integral part of Factor 3 against dietary necrotic liver degeneration J Am Chem Soc 79 3292 3293 10.1021/ja01569a087 1:CAS:528:DyaG2sXnslOmsg%3D%3D
25. JT Rotruck AL Pope HE Ganther AB Swanson DG Hafeman WG Hoekstra 1973 Selenium: Biochemical role as a component of glutathione peroxidase Science 179 588 590 10.1126/science.179.4073.588 1:CAS:528:DyaE3sXps1ensg%3D%3D 4686466
26. SC Low MJ Berry 1996 Knowing when not to stop:selenocysteine incorporation in eukaryotes Trends in Biochem Sci 21 203 208 1:CAS:528:DyaK28Xjs1Kitb0%3D
27. TC Stadtman 1990 Selenium biochemistry Ann Rev Biochem 59 111 127 10.1146/annurev.bi.59.070190.000551 1:CAS:528:DyaK3cXls1Ontr4%3D 2142875
28. M Valko H Morris MT Cronin 2005 Metals, toxicity and oxidative stress Curr Med Chem 12 1161 1208 10.2174/0929867053764635 1:CAS:528: DC%2BD2MXktlant7g%3D 15892631 (Pubitemid 40655271)
29. AS El-Sharaky AA Newairy MM Badreldeen SM Eweda SA Sheweita 2007 Protective role of selenium against renal toxicity induced by cadmium in rats Toxicol 235 185 193 10.1016/j.tox.2007.03.014 1:CAS:528:DC%2BD2sXlsF2lu7w%3D (Pubitemid 46734546)
30. de Freitas AS, Funck VR, Rotta MS, Bohrer D, Mörschbächer V, Puntel RL, Nogueira CW, Farina M, Aschner M, Rocha JB: Diphenyl diselenide, a simple organoselenium compound, decreases methylmercury-induced cerebral, hepatic and renal oxidative stress and mercury deposition in adult mice. Brain Res Bull 2009; 79: 77-87.
31. CG Fraga RF Arias SF Llesuy 1987 Koch OR; Boveris A: Effect of vitamin E- and selenium-deficiency on rat liver chemiluminescence Biochem. J. 242 383 386 1:CAS:528:DyaL2sXhtFymurY%3D 3593258
32. KC Teixeira FS Soares LG Rocha PC Silveira LA Silva SS Valença F Dal Pizzol EL Streck RA Pinho 2008 Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine Pulm Pharmacol Ther 21 309 316 10.1016/j.pupt.2007.07.006 1:CAS:528:DC%2BD1cXivVyitr4%3D 17904883 (Pubitemid 351312673)
33. RA Pinho PC Silveira LA Silva E Luiz Streck F Dal-Pizzol JCF Moreira 2005 N-acetylcysteine and deferoxamine reduce pulmonary oxidative stress and inflamation in rats after coal dust exposure Environ Res 99 355 360 10.1016/j.envres.2005.03.005 1:CAS:528:DC%2BD2MXht1GhtLvN 16307977 (Pubitemid 41676845)
34. C Ritter AA da Cunha IC Echer M Andrades A Reinke N Lucchiari J Rocha EL Streck S Menna-Barreto JC Moreira F Dal-Pizzol 2006 Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat Crit Care Med 34 471 477 10.1097/01.CCM.0000199069.19193.89 1:CAS:528: DC%2BD28Xls1Gguw%3D%3D 16424730 (Pubitemid 43145628)
35. AS Aguiar Jr T Tuon FS Soares LG da Rocha PC Silveira RA Pinho 2008 The effect of N-acetylcysteine and deferoxamine on exercise-induced oxidative damage in striatum and hippocampus of mice Neurochem Res 33 729 736 10.1007/s11064-007-9485-8 1:CAS:528:DC%2BD1cXjsFGit7o%3D 17940892 Epub 2007 Oct 17
36. PB Di-Pietro ML Dias G Scaini M Burigo L Constantino RA Machado F Dal-Pizzol EL Streck 2008 Inhibition of brain creatine kinase activity after renal ischemia is attenuated by N-acetylcysteine and deferoxamine administration Neurosci Lett. 434 139 43 10.1016/j.neulet.2008.01.051 1:CAS:528: DC%2BD1cXjtlyhur0%3D 18304734
37. SS Valvassori FC Petronilho GZ Réus AV Steckert VB Oliveira CR Boeck F Kapczinski F Dal-Pizzol J Quevedo 2008 Effect of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania Prog Neuropsychopharmacol Biol Psychiatry 32 1064 1068 10.1016/j.pnpbp.2008.02. 012 1:CAS:528:DC%2BD1cXls1yrsbw%3D 18403082 (Pubitemid 351609248)
38. JG Schnellmann NR Pumford DF Kusewitt TJ Bucci JA Hinson 1999 Deferoxamine delays the development of the hepatotoxicity of acetaminophen in mice Toxicol Lett. 106 79 88 10.1016/S0378-4274(99)00021-1 1:CAS:528: DyaK1MXjvFyntLk%3D 10378453 (Pubitemid 29216949)
39. C Ritter A Reinke M Andrades MR Martins J Rocha S Menna-Barreto J Quevedo JC Moreira F Dal-Pizzol 2004 Protective effect of N-acetylcysteine and deferoxamine on carbon tetrachloride-induced acute hepatic failure in rats Crit Care Med 32 10 2079 83 10.1097/01.CCM.0000142699.54266.D9 1:CAS:528: DC%2BD2cXosVSltrw%3D 15483417 (Pubitemid 39372542)
40. Sweetman SC: Martindale. The Complete Drug Reference, 33 rd edition, 2002, The Pharmaceutical Press, London, pp: 1082.
41. M Yaǧmurca O Bas H Mollaoglu O Sahin A Nacar O Karaman A Songur 2007 Protective effects of erdosteine on doxorubiicn-induced hepatotoxicity in rats Arch Med Res 38 380 385 10.1016/j.arcmed.2007.01.007 17416283 (Pubitemid 46528559)
42. JH Doroshow GY Locker CE Myers 1980 Enzymatic defenses of mouse hearth against reactive oxygen metabolites J Clin Invest 65 128 135 10.1172/JCI109642 1:CAS:528:DyaL3cXovVyruw%3D%3D 7350193